Epirubicin or epirubicin and cisplatin as first-line therapy in advanced breast cancer. A phase III study
- 4 December 2000
- journal article
- clinical trial
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 46 (6) , 459-466
- https://doi.org/10.1007/s002800000178
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: